首页> 外文OA文献 >Neoadjuvant endocrine therapy in locally advanced estrogen or progesterone receptor-positive breast cancer: determining the optimal endocrine agent and treatment duration in postmenopausal women—a literature review and proposed guidelines

【2h】

Neoadjuvant endocrine therapy in locally advanced estrogen or progesterone receptor-positive breast cancer: determining the optimal endocrine agent and treatment duration in postmenopausal women—a literature review and proposed guidelines

机译：Neoadjuvant内分泌治疗在局部晚期雌激素或黄体酮受体阳性乳腺癌：确定绝经后妇女的最佳内分泌剂和治疗持续时间 - 是文献审查和拟议指导方针

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Lauren I. Madigan; Phuong Dinh; J. Dinny Graham;
展开▼
作者单位

展开▼
年度 2020
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Neoadjuvant endocrine therapy in locally advanced estrogen or progesterone receptor-positive breast cancer: determining the optimal endocrine agent and treatment duration in postmenopausal women—a literature review and proposed guidelines [J] . Lauren I. Madigan, Phuong Dinh, J. Dinny Graham Breast Cancer Research . 2020,第1期

机译：Neoadjuvant内分泌治疗在局部晚期雌激素或黄体酮受体阳性乳腺癌：确定绝经后妇女的最佳内分泌剂和治疗持续时间 - 是文献审查和拟议指导方针
2. New agents in the first line treatment of metastatic or locally advanced endocrine positive, her-2eu negative breast cancer in postmenopausal women. A review [J] . Nicolae BACALBASA Archives of the Balkan Medical Union : . 2017,第1期

机译：一线新药可治疗绝经后妇女转移性或局部晚期内分泌阳性，her-2 / neu阴性乳腺癌。回顾
3. Network Meta-Analysis Comparing Overall Survival for Fulvestrant 500 mg Versus Alternative Therapies for Treatment of Postmenopausal, Estrogen Receptor-Positive Advanced Breast Cancer Following Failure on Prior Endocrine Therapy [J] . Telford Claire, Jones Nick, Livings Christopher, Clinical breast cancer . 2016,第3期

机译：网络荟萃分析比较氟维西特500 mg的总生存率与替代药物治疗绝经后，雌激素受体阳性晚期乳腺癌在先前内分泌治疗失败后的总生存率
4. Functional Imaging of Neoadjuvant Chemotherapy Response in Women with Locally Advanced Breast Cancer using Diffuse Optical Spectroscopy [C] . Hany Soliman, Martin J. Yaffe, Gregory J. Czarnota Annual International Conference of the IEEE Engineering in Medicine and Biology Society . 2009

机译：弥漫光学光谱学局部晚期乳腺癌女性新辅助化疗反应的功能成像
5. A time to question: A study of the information needs of postmenopausal breast cancer patients regarding endocrine therapy. [D] . TeBrake, Melissa Lynn. 2010

机译：问题时间：对绝经后乳腺癌患者有关内分泌治疗的信息需求的研究。
6. Neoadjuvant endocrine therapy in locally advanced estrogen or progesterone receptor-positive breast cancer: determining the optimal endocrine agent and treatment duration in postmenopausal women—a literature review and proposed guidelines [O] . Lauren I. Madigan, Phuong Dinh, J. Dinny Graham 2020

机译：Neoadjuvant内分泌治疗在局部晚期雌激素或黄体酮受体阳性乳腺癌：确定绝经后妇女的最佳内分泌剂和治疗持续时间 - 是文献审查和拟议指导方针
7. Neoadjuvant letrozole in postmenopausal estrogen and/or progesterone receptor positive breast cancer: A phase IIb/III trial to investigate optimal duration of preoperative endocrine therapy [O] . 2008

机译：绝经后雌激素和/或孕激素受体阳性乳腺癌的新辅助来曲唑：一项IIb / III期临床试验，研究术前内分泌治疗的最佳持续时间

Neoadjuvant endocrine therapy in locally advanced estrogen or progesterone receptor-positive breast cancer: determining the optimal endocrine agent and treatment duration in postmenopausal women—a literature review and proposed guidelines

著录项

相似文献

相关主题

期刊订阅